Difference between revisions of "Main Page"

From OmniJournal
Jump to navigation Jump to search
(Replaced content with "{{Main page}}<!-- -- To edit what appears on this page, -- please see Template:Main_page -- https://omnij.org/Template:Main_page -->")
Tag: Replaced
Line 1: Line 1:
<strong>Omni Journal</strong>
{{Main page}}<!--
-- To edit what appears on this page,
Consult the [https://www.mediawiki.org/wiki/Special:MyLanguage/Help:Contents User's Guide] for information on using the wiki software.
-- please see [[Template:Main_page]]
-- https://omnij.org/Template:Main_page
= Articles =
# [[Hydroxychloroquine_or_chloroquine_with_or_without_a_macrolide_for_treatment_of_COVID-19:_a_multinational_registry_analysis|Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis]]
# [[Outcomes_of_hydroxychloroquine_usage_in_United_States_veterans_hospitalized_with_Covid-19|Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19]]
= About OmniJournal =
OmniJournal is an open collaboration focused on the review of scientific publications and discoveries in real-time. '''Content is continually created and edited by anyone''' with the shared goal of expediently validating or rejecting medical and scientific discoveries.
== Peer-review in the information age ==
The traditional peer-review process for medical and scientific discoveries is slow, non-collaborative and nontransparent. These truths have become self-evident during the COVID-19 pandemic.
'''OmniJournal is fast.''' Journals can take months to peer-review manuscripts without any guarantee of publication. Upon rejection, authors must then start the submission process again in another journal. Without real-time feedback, this process is inefficient and delays public dissemination of critical information relating to medical and scientific discovery.
Preprints are increasingly becoming the preferred method of bypassing this time-consuming process. To date, however, there is not a suitable platform for the peer-review of preprint articles.
'''On OmniJournal, both published articles and preprints can be immediately scrutinized in real-time by anyone in an organized single page.'''
'''OmniJournal is collaborative.''' Scientific discovery is most successful when done in collaboration. Traditional peer-review, however, occurs in isolation. Expert reviewers are not permitted to collaborate with colleagues and are confined to reviewing article submissions in secrecy. The result is wasted effort by reviewers who may spend considerable amounts of time discovering identical issues. The peer-review process is further weakened because reviewing experts with varying skill sets cannot build off each other's discoveries.
A collaborative effort can result in a far more rigorous peer-review process. For example, an expert in the subject matter may be surprised or suspicious of a particular finding, but may not have the command of statistical analysis to validate these suspicions. On OmniJournal, a subject matter expert could point out a suspicious finding, which would then guide a statistician to validate a particular data set.
'''Omnijournal allows experts to build off each other’s knowledge base in real-time to validate scientific papers.'''
'''OmniJournal is transparent.''' Traditional peer-review is notoriously a “black box” whereby the public along with scientists and physicians, are largely expected to trust journals to act in the best interest of science. This trust is called into question though. Multiple current and former editors-in-chief of high-impact journals (e.g. The Lancet, NEJM) have openly stated that journals are increasingly beholden to pharmaceutical companies, who provide the vast majority of funding to journal organizations in the form of advertising or sponsorships.
Editors-in-chief are wholly in control of the publication and are also beholden to interested for-profit corporations. Moreover, editors-in-chief are subject to their own political or scientific biases, which may suppress certain scientific discoveries while amplifying others. Both journals and editors-in-chief are centralized points of control that are subject to biases and external influences.
'''OmniJournal decentralizes control to reduce scientific bias.'''
== Design ==
Anyone is allowed to add and edit content on OmniJournal immediately after creating an account.
Any scientific publication, pre-print or news release reporting a scientific discovery can be validated on OmniJournal by creating a page linking the publication or news release. The entry is to include the relevant publication details that identify the original article.
Minimum suggested content for each page includes a brief '''Summary''' of the paper’s findings along with '''Major Issues''' (e.g. methodology concerns, insufficient data, flaws in statistical analysis), '''Minor Issues''' (e.g. references, ambiguous sentences), '''Impact''' (e.g. implications of findings) and '''References'''. When applicable, there will be an '''Authors’ Response''' where verified authors can non-anonymously address raised concerns or questions.
In the future, authors may elect to submit original articles directly to OmniJournal, but this feature is not necessary today. As demand for this feature grows, functionality can be easily added to the platform.
'''The result is a collaborative peer-review of scientific articles in an easily digestible and recognizable format.'''
== System Administrators ==
'''James Todaro, MD'''
Dr. Todaro received his medical degree from Columbia University, Vagelos College of Physicians and Surgeons in NY, followed by completion of residency in ophthalmology.
He continues to lead research in COVID-19 at a global scale, with multiple publications including the first widely disseminated paper on chloroquine in treatment of COVID-19 in An Effective Treatment for Coronavirus (COVID-19), and, most recently the first detailed exposé on Surgisphere and the retracted Lancet study in A Study Out of Thin Air.
'''Steve Sperandeo'''
Steve is a software engineer and architect with over 15 years of experience. He is particularly interested in data science and using technology to advance science and improve people's and animals' well-being. While bias cannot be fully removed from science, where there is bias in science, Steve endeavours to mitigate it through creative applications of technology.

Latest revision as of 19:22, 5 July 2020